GREY:ATBPF - Post by User
Comment by
jplordureon Oct 07, 2015 9:34am
93 Views
Post# 24170920
RE:Antibe buys a new company... Why? ATB-346 doesn't work?
RE:Antibe buys a new company... Why? ATB-346 doesn't work?Great bashing!
BeenHereBefore wrote: So Antibe acquires a new company, presumably with safe and effective products... Is that because the next news release will announce that ATB-346 failed (yet again) during the mandatory 3rd-party validation studies?
Is Antibe working on a classic "shareholder attention redirect?" Shouldn't be too hard. Near-term shareholder memory is already corrupted, what with so many people once again pumping the greatness of a drug that poisoned people's livers and required Phase I human trials to be suspended less than nine months ago. All is quickly forgiven by underwater shareholders looking to get out of the hole they're in.
Key quote from the NR:
"We believe that these transactions will provide new avenues of growth for Antibe..." Yeah, new avenues (orthodontics? bone regeneration?) when they can no longer hide the fact that the old avenue (ATB-346) has failed.
Translation: Our much hyped product won't be coming to market but look at the shiny new company we bought! Derrrp.
The timing is right for a little subterfuge. Validation results are due by the end of the year. Maybe Antibe is preparing for the worst and hoping to soften the blow with this very "strategic" acquisition.